Availability of Orkambi on the NHS: request for documents update
6 December 2018
On Friday 30 November the Health and Social Care Committee received documents from Vertex Pharmaceuticals, NHS England and the National Institute for Health and Care Excellence (NICE).
These documents are now being assessed, with the assistance of the Committee's specialist adviser, Prof Mark Sculpher of the Centre for Health Economics at the University of York. The Committee will decide on further action in due course.
The Committee is grateful to the three relevant organisations for the documents they have sent and looks forward to further cooperation as its inquiry progresses.